Works matching IS 13520504 AND DT 2018 AND VI 25 AND IP 2

Results: 16

Innovative technologies for point‐of‐care testing of viral hepatitis in low‐resource and decentralized settings.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 2, p. 108, doi. 10.1111/jvh.12827

By:

Duchesne, L.;
Lacombe, K.

Publication type:

Article

Prevalence of hepatitis C infection and its associated factors in healthy adults without identifiable route of transmission.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 2, p. 161, doi. 10.1111/jvh.12804

By:

Wong, N. S.;
Lee, C. K.;
Ng, S. C.;
Wong, H. K.;
Chan, D. P. C.;
Lee, S. S.

Publication type:

Article

Trends in hepatitis C‐related mortality in Switzerland.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 2, p. 152, doi. 10.1111/jvh.12803

By:

Keiser, O.;
Giudici, F.;
Müllhaupt, B.;
Junker, C.;
Dufour, J. ‐F.;
Moradpour, D.;
Bruggmann, P.;
Terziroli, B.;
Semela, D.;
Brezzi, M.;
Bertisch, B.;
Estill, J.;
Negro, F.;
Spoerri, A.;
the Swiss Hepatitis C Cohort Study and the Swiss National Cohort

Publication type:

Article

Eighteen‐month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 2, p. 198, doi. 10.1111/jvh.12802

By:

Marrone, A.;
Capoluongo, N.;
D'Amore, C.;
Pisaturo, M.;
Esposito, M.;
Guastafierro, S.;
Siniscalchi, I.;
Macera, M.;
Boemio, A.;
Onorato, L.;
Rinaldi, L.;
Minichini, C.;
Adinolfi, L. E.;
Sagnelli, E.;
Mastrullo, L.;
Coppola, N.

Publication type:

Article

Treatment of hepatitis C with 8 weeks of ledipasvir/sofosbuvir: Highly effective in a predominantly black male patient population.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 2, p. 205, doi. 10.1111/jvh.12796

By:

Tang, L.;
Parker, A.;
Flores, Y.;
Dellario, M.;
Dickson, C.;
Amoroso, A.;
Kottilil, S.;
Wilson, E.

Publication type:

Article

Genotype 4 hepatitis E virus is a cause of chronic hepatitis in renal transplant recipients in Hong Kong.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 2, p. 209, doi. 10.1111/jvh.12799

By:

Sridhar, S.;
Chan, J. F. W.;
Yap, D. Y. H.;
Teng, J. L. L.;
Huang, C.;
Yip, C. C. Y.;
Hung, I. F. N.;
Tang, S. C. W.;
Lau, S. K. P.;
Woo, P. C. Y.;
Yuen, K.‐Y.

Publication type:

Article

Sustained virological response to ombitasvir/paritaprevir/ritonavir and dasabuvir treatment for hepatitis C: Real‐world data from a large healthcare provider.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 2, p. 144, doi. 10.1111/jvh.12800

By:

Weil, C.;
Mehta, D.;
Koren, G.;
Pinsky, B.;
Samp, J. C.;
Chodick, G.;
Shalev, V.

Publication type:

Article

Bacterial translocation and clinical progression of HCV‐related cirrhosis in HIV‐infected patients.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 2, p. 180, doi. 10.1111/jvh.12769

By:

Merchante, N.;
Aldámiz‐Echevarría, T.;
García‐Álvarez, M.;
Rivero‐Juárez, A.;
Macías, J.;
Miralles, P.;
Jiménez‐Sousa, M. A.;
Mancebo, M.;
Pérez‐Latorre, L.;
Pineda‐Tenor, D.;
Berenguer, J.;
Resino, S.;
Pineda, J. A.

Publication type:

Article

Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus‐co‐infected patients (ANRS CO13‐HEPAVIH).

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 2, p. 171, doi. 10.1111/jvh.12797

By:

Nordmann, S.;
Vilotitch, A.;
Roux, P.;
Esterle, L.;
Spire, B.;
Marcellin, F.;
Salmon‐Ceron, D.;
Dabis, F.;
Chas, J.;
Rey, D.;
Wittkop, L.;
Sogni, P.;
Carrieri, P.;
ANRS CO13 HEPAVIH Study Group

Publication type:

Article

Resistance characterization of ledipasvir and velpatasvir in hepatitis C virus genotype 4.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 2, p. 134, doi. 10.1111/jvh.12795

By:

Camus, G.;
Han, B.;
Asselah, T.;
Hsieh, D.;
Dvory‐Sobol, H.;
Lu, J.;
Svarovskaia, E.;
Martin, R.;
Parhy, B.;
Miller, M. D.;
Brainard, D. M.;
Kersey, K.;
Abergel, A.;
Mo, H.

Publication type:

Article

Efficacy and safety results of patients with HCV genotype 2 or 3 infection treated with ombitasvir/paritaprevir/ritonavir and sofosbuvir with or without ribavirin (QUARTZ II‐III).

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 2, p. 118, doi. 10.1111/jvh.12782

By:

Shafran, S. D.;
Shaw, D.;
Charafeddine, M.;
Agarwal, K.;
Foster, G. R.;
Abunimeh, M.;
Pilot‐Matias, T.;
Pothacamury, R. K.;
Fu, B.;
Cohen, E.;
Cohen, D. E.;
Gane, E.

Publication type:

Article

Rare clinically significant hepatic events and hepatitis B reactivation occur more frequently following rather than during direct‐acting antiviral therapy for chronic hepatitis C: Data from a national US cohort.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 2, p. 187, doi. 10.1111/jvh.12784

By:

Serper, M.;
Forde, K. A.;
Kaplan, D. E.

Publication type:

Article

Nonstructural protein 5A resistance profile in patients with chronic hepatitis C treated with ledipasvir‐containing regimens without sofosbuvir.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 2, p. 126, doi. 10.1111/jvh.12783

By:

Kitrinos, K. M.;
Corsa, A. C.;
Worth, A.;
Hedskog, C.;
Brainard, D. M.;
Miller, M. D.;
Mo, H.

Publication type:

Article

Issue Information.

Published in:: Journal of Viral Hepatitis, 2018, v. 25, n. 2, p. 105, doi. 10.1111/jvh.12771
Publication type:: Article

Successful treatment of chronic hepatitis C with ground ledipasvir/sofosbuvir in a patient with Crohn's disease and short bowel syndrome.

Published in:

2018

By:

von Felden, J.;
Scheurich, C.;
Yamamura, J.;
Brainard, D. M.;
Mogalian, E.;
Lohse, A. W.;
Schulze zur Wiesch, J.

Publication type:

Letter to the Editor

Cover Image.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 2, p. i, doi. 10.1111/jvh.12596

By:

Camus, G.;
Han, B.;
Asselah, T.;
Hsieh, D.;
Dvory‐Sobol, H.;
Lu, J.;
Svarovskaia, E.;
Martin, R.;
Parhy, B.;
Miller, M. D.;
Brainard, D. M.;
Kersey, K.;
Abergel, A.;
Mo, H.

Publication type:

Article